[EN] PRODRUGS OF INHIBITORS OF PLASMA KALLIKREIN<br/>[FR] PROMÉDICAMENTS D'INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE
申请人:ACTIVESITE PHARMACEUTICALS INC
公开号:WO2011075684A1
公开(公告)日:2011-06-23
The present invention provides prodrugs of compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating plasma kallikrein dependent diseases or conditions, for example, diabetic macular edema, with the prodrugs having the formula (I).